In addition to that, previous studies have shown that intracavitary levels of IL-12 in GBM are lower than others anti-inflammatory cytokines (e.g., IL-8) resulting in the interest of using recombinant IL-12 as immunoadjuvant for GBM [10, 11]. Here, CXCL8 is linked to glioblastoma.